## min read

The Difference Between Learning Disabilities and ADHD

|

April 18, 2025

Summarize with AI

The Difference Between Learning Disabilities and ADHD

Picture a classroom where two students are struggling with their reading assignment. Michael reads slowly, mixing up letters despite his best efforts to focus. Meanwhile, Olivia reads fluently but can't sit long enough to finish a page. Michael has a learning disability called dyslexia, while Olivia has ADHD. Though both students face challenges, their underlying difficulties are quite different. Understanding these differences is crucial for parents, teachers, and healthcare providers. This guide explores how these conditions differ and, most importantly, how to support each unique situation.

What Are Learning Disabilities (LD) and ADHD?

Defining Learning Disabilities (LD)

A learning disability affects how the brain processes information. Think of it as a unique wiring system in the brain. People with learning disabilities often have average or above-average intelligence. Their challenges lie in specific areas of learning.

Common types of learning disorders include:

  • Dyslexia: Words seem to jump around on the page. Reading becomes challenging even when other academic areas remain strong. Students might reverse letters or struggle with phonetic sounds. Simple reading tasks can require significant mental effort.
  • Dyscalculia: Math feels like solving a puzzle in another language. Basic calculations become complex challenges. Students might struggle to understand number sequences or mathematical patterns. Time-telling and money management often present unique difficulties.
  • Dysgraphia: Writing becomes a physical challenge. Letters refuse to form correctly on paper. Students experience hand fatigue during writing tasks. Spacing between words and letter formation requires extra concentration.
  • Auditory Processing Disorder: Spoken information gets mixed up between hearing and understanding. Following verbal instructions becomes particularly challenging. Background noise can severely impact comprehension of spoken words.
  • Visual Processing Disorder: The eyes work perfectly, but the brain mixes visual information. It affects reading speed and understanding of written material. Visual organization and spatial awareness present significant challenges.

Understanding ADHD

ADHD creates unique processing challenges in the brain. It affects how people manage daily tasks and activities. The brain struggles with focus and impulse control throughout various situations. It impacts school, work, and social interactions.

Executive functions work differently in people with ADHD. Simple tasks might feel overwhelming. Many everyday activities require extra mental effort. It makes daily routines more challenging than they appear.

Three distinct types of learning disorders present different challenges:

  • The Inattentive Type: Focus drifts easily during tasks, like a radio station that keeps losing signal. Details often get overlooked, even in familiar activities. Starting and finishing projects requires extra effort, making simple assignments feel like complex puzzles. Getting through daily tasks becomes a constant challenge.
  • The Hyperactive-Impulsive Type: Staying still feels like holding back a strong wind. Actions happen before thoughts are complete, similar to pressing 'send' before finishing an email. Speaking out of turn occurs frequently, making conversations challenging. Energy levels stay consistently high throughout the day.
  • The Combined Type: This type mixes attention difficulties with hyperactive behaviors. Tasks remain incomplete while energy levels stay high. Daily activities require extra support and understanding. Managing both symptoms creates unique challenges in all situations.

Everyone experiences symptoms differently depending on their environment and daily schedule. Some find mornings most challenging. Others struggle more during quiet afternoon activities. Understanding these patterns helps create better support strategies.

Key Differences Between Learning Disabilities and ADHD

Focus on Specific vs. Global Skills

Learning disabilities target specific academic skills. Meanwhile, ADHD affects overall attention and behavior management. This fundamental difference shapes how each condition impacts daily life. The impact varies significantly:

Area of Impact Learning Disabilities (LD) ADHD
Academic Skills Struggles with specific subjects while excelling in others Performance varies across all subjects based on interest and focus
Reading Ability May have specific reading difficulties (dyslexia) Can read well but loses focus during reading tasks
Math Skills Might struggle specifically with calculations (dyscalculia) Can understand math but makes careless errors due to inattention
Writing Tasks May have trouble forming letters or expressing ideas in writing Writing is rushed, disorganized, or left incomplete
Attention Span Generally able to focus but struggles with specific tasks Difficulty maintaining attention across all activities
Organization Usually capable of keeping materials and spaces organized Consistently struggles with organization in all areas
Task Completion Completes tasks but may take longer in specific areas Starts many tasks but has trouble finishing them
Social Skills Social abilities typically unaffected by the disability May struggle with turn-taking and reading social cues
Memory Specific memory challenges related to disability area General difficulties with working memory and recall
Following Instructions Can follow directions but may need help in specific areas Trouble remembering and following multi-step instructions
Test Performance Consistent difficulties in specific subject areas Variable performance depending on attention level
Project Planning Generally able to plan and execute projects Struggles with project planning and time management

Impact on Executive Functions

Executive functions play a crucial role in daily activities. These brain-based skills affect how people manage tasks and behaviors.

People with learning disabilities usually maintain strong executive function skills. They can:

  • Plan activities effectively
  • Organize materials systematically
  • Manage time appropriately
  • Control impulses successfully
  • Complete tasks once started
  • Switch between activities smoothly

Those with ADHD often struggle with executive function skills. They experience challenges with:

  • Creating and following plans
  • Keeping materials organized
  • Managing time effectively
  • Controlling immediate reactions
  • Completing started tasks
  • Transitioning between activities

How Are They Diagnosed?

Diagnostic Criteria for LD

Learning disability diagnosis requires comprehensive evaluation. The process includes multiple steps and assessments. Key components of LD diagnosis:

  • Standardized achievement testing
  • Cognitive ability assessment
  • Educational history review
  • Classroom performance observation
  • Work sample analysis
  • Specific skill evaluation
  • Parent and teacher input

ADHD Diagnosis

ADHD diagnosis follows a different path. It focuses on behavioral patterns across various settings. Essential elements of ADHD diagnosis:

  • Behavioral observation
  • Parent and teacher ratings
  • Medical examination results
  • Developmental history review
  • Multiple setting evaluations
  • Executive function assessment
  • Symptom duration analysis

Challenges in Diagnosis

Several factors can complicate accurate diagnosis:

  • Overlapping symptoms between conditions
  • Varying presentations in different environments
  • Age-related symptom changes
  • Environmental influence on behavior
  • Cultural considerations in assessment
  • Access to qualified professionals

Treatment and Support for LD and ADHD

Managing Learning Disabilities

Effective support for learning disabilities requires targeted intervention strategies. Key support elements include:

  • Specialized instruction methods
  • Assistive technology tools
  • Educational accommodations
  • Remedial skill building
  • Progress monitoring systems
  • Parent-teacher collaboration

Strategies for ADHD

ADHD management requires a comprehensive approach. Different strategies address various aspects of the condition. Essential management components:

  • Behavioral modification techniques
  • Environmental adaptations
  • Organizational systems
  • Time management tools
  • Activity scheduling
  • Routine establishment

Support for Co-occurring Conditions

Many individuals experience both conditions simultaneously. It requires carefully coordinated support approaches. Combined support strategies include:

  • Integrated treatment planning
  • Multi-specialist coordination
  • Regular progress assessment
  • Flexible intervention methods
  • Family education programs
  • School-home communication systems

Why Understanding the Difference Matters

Tailoring Interventions

Understanding differences between conditions leads to more effective support. Proper identification helps create targeted assistance plans. Important considerations include:

  • Specific skill development needs
  • Individual learning preferences
  • Environmental modification requirements
  • Support service selection
  • Progress measurement methods
  • Accommodation appropriateness

Supporting Children and Families

Proper understanding enables better support from all involved parties. This knowledge helps create effective support networks. Support network components include:

  • Parent education resources
  • Teacher training programs
  • Healthcare provider coordination
  • Therapeutic service access
  • Community support systems

Conclusion: Empowering Success Through Understanding

Understanding the differences between learning disabilities and ADHD enables better support. This knowledge helps create effective intervention strategies. Success becomes possible through appropriate understanding and targeted assistance.

Key takeaway points include:

  • Distinct nature of each condition
  • Importance of accurate diagnosis
  • Value of targeted interventions
  • Need for ongoing support
  • Significance of proper understanding
  • Potential for successful outcomes

Individuals with these conditions can achieve significant success with proper support and understanding. Recognition of differences leads to more effective assistance strategies. This understanding helps create pathways to achievement and growth.

Personalized Support at Amae Health

At Amae Health, we recognize the unique challenges individuals face when living with learning disabilities or ADHD. Our team of compassionate clinicians and mental health experts is dedicated to providing personalized, evidence-based care that addresses each person’s specific needs. Whether you're seeking clarity through diagnosis or ongoing support for cognitive, emotional, or behavioral health, Amae Health offers a safe and supportive environment where healing and growth can begin.

‍

Reccomended for you

# min read

TMS vs Medication: Comparing Depression Treatments

By

Sonia Garcia

|

September 23, 2026

Most people comparing TMS vs medication for depression arrive at the question the same way: the antidepressants have not brought enough relief. If that is you, it helps to know that both are evidence-based, FDA-cleared treatments, and they work in completely different ways. Medication adjusts brain chemistry from the inside. TMS stimulates the brain directly with magnetic pulses. Neither is universally better. The right choice depends on your treatment history, the severity of your symptoms, how you tolerate side effects, and your own preferences, especially once you are dealing with treatment-resistant depression or trying to figure out what to do when antidepressants don't work. This article compares the two fairly, not to push one over the other.

How Antidepressants Work

Antidepressants change the availability of certain brain chemicals, mainly serotonin and norepinephrine, that influence mood. The most common are SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors). Both are considered first-line treatment, meaning they are usually where a clinician starts.

‍

They are taken daily as a pill at home, and they work gradually. Most people need several weeks before the full effect shows, which is one of the harder parts of starting an antidepressant: you often have to wait to know whether it is working. Finding the right medication and dose regularly takes some trial and adjustment, and a first medication that does not help does not mean none will. There are many options within each class, so a clinician can switch or fine-tune based on how a person responds. Older tricyclic antidepressants (TCAs) also work but tend to cause harsher side effects, so they are usually reserved for later steps rather than first-line use. The main appeal of medication is convenience and evidence: it is taken at home, it is inexpensive, and it has decades of research behind it.

How TMS Works

Transcranial magnetic stimulation (TMS) is a non-invasive treatment that uses focused magnetic pulses, similar in strength to an MRI, to stimulate the mood-regulating areas of the brain that tend to be underactive in depression, mainly the left dorsolateral prefrontal cortex. It is FDA-cleared for major depressive disorder in adults, and also for OCD (NIMH, Brain Stimulation Therapies).

‍

TMS is not electroconvulsive therapy (ECT). There is no anesthesia and no sedation, and the patient stays fully awake through each session, then drives home and returns to normal activity. During a session, a coil rests against the scalp and delivers pulses in short cycles, which most people feel as a tapping sensation. A typical course runs about five days a week for several weeks, with each session lasting under an hour, and the benefit tends to build gradually across the course rather than after any single visit.

‍

As a non-drug option, TMS is one of the main alternatives to antidepressants for people whose medication has stopped short. It usually works best as part of a broader treatment plan, coordinated with therapy and, in many cases, ongoing medication, rather than as a replacement for all other care.

TMS vs Medication: Side-by-Side Comparison

The two treatments differ on almost every practical dimension, from how they are delivered to how quickly they work and what they ask of you day to day. The table below lays the key differences side by side, and the sections that follow unpack the two that matter most to people making this decision: side effects and success rates.

Factor Antidepressants TMS
How it works Adjusts brain chemistry (daily medication) Magnetic pulses stimulate mood-regulating brain areas
Schedule Daily pill, at home In-clinic sessions, about 5 days a week for several weeks
Onset Several weeks Often within a few weeks of the course
Common side effects Weight change, sexual dysfunction, fatigue, sleep changes Mild scalp discomfort or headache, usually fades after the first week
Effect on memory or cognition Varies by medication No known negative effect on memory or cognition
Best positioned for First-line, mild to moderate depression When medication has not worked or side effects are intolerable

Side Effects Compared

Antidepressant side effects vary by class. SSRIs commonly cause weight gain and sexual dysfunction, though some effects ease after the first few weeks. SNRIs have a similar profile that is often milder. TCAs tend to be harsher, which is why they are rarely a first choice. These are systemic effects, because the medication acts throughout the body.

‍

TMS side effects are usually mild and short-lived: scalp discomfort, headache, or lightheadedness that typically passes soon after a session and lessens over the first week. The most serious risk, seizure, is very rare. Because TMS is non-invasive and targeted rather than systemic, it avoids the weight, sexual, and sleep side effects associated with medication, and it does not affect memory or cognition the way some people fear based on older brain treatments like ECT.

‍

It is not side-effect-free, though, and its main practical downside is different in kind. Instead of a daily side effect, TMS asks for a time commitment: traveling to a clinic most weekdays for several weeks. For someone with a demanding schedule or limited transportation, that logistical cost is real and worth weighing against the appeal of avoiding medication side effects. Neither profile is automatically easier to live with; they are simply different, and which one fits depends on the person.

Success Rates: What the Research Shows

Both treatments help many people, and neither helps everyone. Reading the numbers honestly matters more than cheerleading for either one. Two terms come up often: response means a meaningful reduction in symptoms, usually cutting them roughly in half, while remission means symptoms largely resolve. Remission is the higher bar and the real goal.

‍

For medication, the landmark STAR*D study found that roughly a third of patients reached remission on their first SSRI (Trivedi et al., American Journal of Psychiatry, 2006). That is a genuinely useful result for many people. But it also means most did not remit on the first try, and STAR*D showed that with each additional medication tried after a failure, the odds of remission tend to drop while side-effect burden tends to rise. That diminishing return is exactly the situation that leads people to look at other options.

‍

For TMS, a large real-world registry of more than 5,000 patients found that most experienced measurable improvement, with response rates ranging from about 58% to 83% and remission from about 28% to 62%, depending on how outcomes were measured (Sackeim et al., Journal of Affective Disorders, 2020). The wide ranges are worth noting: they reflect different rating scales and patient groups, and many of those patients were also taking medication, so the numbers describe TMS in real-world use rather than in isolation.

‍

For treatment-resistant depression specifically, a 2024 randomized trial compared TMS with switching or augmenting medication in 89 people who had not responded to at least two antidepressants, with both groups also receiving psychotherapy. The TMS group had significantly higher response and remission rates than the medication group (Dalhuisen et al., American Journal of Psychiatry, 2024). It is one of the clearest head-to-head comparisons available, though individual results always vary, and these figures describe groups, not guarantees for any one person.

When Antidepressants Don't Work: Where TMS Fits

About a third of people with major depressive disorder do not respond adequately to first-line treatment, a pattern clinicians call treatment-resistant depression. It is not a sign of personal failure or a rare edge case; it is common, and it has its own growing set of treatment options. When two or more medications have failed, or when side effects are intolerable, TMS becomes a well-supported next step, and the 2024 trial above is part of why it is increasingly positioned early in the treatment-resistant pathway rather than as a last resort.

‍

TMS is not the only option at this stage. Spravato (esketamine), a nasal spray derived from ketamine, is FDA-approved for treatment-resistant depression when used together with an oral antidepressant. It is given in a certified clinic under medical supervision, with monitoring after each dose, because of its dissociative effects. Combining TMS with an antidepressant is another route, and research suggests the combination can improve outcomes over medication alone. The larger point is that once first-line medication falls short, the path forward branches into several evidence-based options, and those branches are not mutually exclusive. A person might use medication and TMS together, or move from one approach to another as their psychiatrist learns what their brain responds to.

Who Is Each Treatment For?

Medication is often the right starting point for someone who is:

‍

  • Early in treatment for depression
  • Managing mild to moderate symptoms
  • Looking to avoid in-clinic visits
  • Someone who has responded well to an antidepressant before

‍

TMS is generally considered for someone who:

‍

  • Has tried multiple antidepressants without adequate relief
  • Cannot tolerate medication side effects
  • Prefers a non-drug approach
  • Has treatment-resistant depression

‍

Many people use both at different points, and some use them together. Where a person lands is a clinical decision, not a solo consumer choice, and it belongs with a psychiatrist who knows the full history.

Making the Decision With a Psychiatrist

TMS, medication, Spravato, and therapy are not competing products. They are tools a psychiatrist combines and adjusts based on diagnosis, history, and how a person responds over time. Comparing TMS and medication on paper is useful, but the decision is rarely either-or, and it is rarely one-and-done. It usually looks more like a sequence: start somewhere reasonable, measure the response, and adjust. The most reliable way to navigate that sequence, and to change course when needed, is a thorough evaluation within an integrated care setting, where the clinician managing your medication is the same one weighing whether TMS or another option fits.

‍

That is how care works at Amae Health. Our psychiatry-led teams evaluate the whole picture and coordinate treatment across medication, therapy, and procedures like TMS, which we offer at our Los Angeles clinic. You can explore our full range of treatments or, for severe depression that needs more structure, our Partial Hospitalization Program. Our resources for patients and families explain how integrated care works, and you can contact our team to ask about an evaluation.

Frequently Asked Questions

Is TMS better than medication for depression? Neither is universally better. Medication is first-line and works well for many people. For treatment-resistant depression, where two or more medications have failed, TMS often outperforms a medication switch. The right choice depends on history, severity, and side-effect tolerance.

‍

Can you do TMS and take antidepressants at the same time? Yes. TMS can be combined with antidepressants, and research suggests the combination can improve outcomes compared with medication alone. This should be coordinated by a psychiatrist.

‍

What are the side effects of TMS vs medication? TMS side effects are usually mild and short-lived, mainly scalp discomfort or headache that fades after the first week. Medication side effects vary but can include weight change, sexual dysfunction, and fatigue. Because it is non-invasive, TMS avoids the systemic side effects of medication.

‍

Does TMS work when antidepressants don't? Often, yes. TMS is specifically supported for treatment-resistant depression. A 2024 randomized trial found higher response and remission rates with TMS than with switching medications after failed trials. Individual results vary.

‍

How long does TMS treatment take? A typical course is sessions about five days a week for several weeks, each lasting under an hour. Antidepressants, by contrast, are taken daily and may take several weeks to show their full effect.

‍

What if neither TMS nor medication works? Other options exist, including Spravato (esketamine) used with an oral antidepressant, combination approaches, and structured programs like IOP or PHP for severe depression. A psychiatrist can help identify next steps. Depression is hard, and support is available: if you are struggling, call or text the 988 Suicide and Crisis Lifeline at 988, anytime.

‍

Citations

  1. Trivedi MH, Rush AJ, Wisniewski SR, et al. "Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D." American Journal of Psychiatry, 2006. psychiatryonline.org. Tier 1 (peer-reviewed).
  2. Sackeim HA, Aaronson ST, Carpenter LL, et al. "Clinical outcomes in a large registry of patients with major depressive disorder treated with transcranial magnetic stimulation." Journal of Affective Disorders, 2020. sciencedirect.com. Tier 1 (peer-reviewed).
  3. Dalhuisen I, van Oostrom I, Spijker J, et al. "rTMS as a Next Step in Antidepressant Nonresponders: A Randomized Comparison With Current Antidepressant Treatment Approaches." American Journal of Psychiatry, 2024. PubMed 39108161. Tier 1 (peer-reviewed RCT).
  4. National Institute of Mental Health, "Brain Stimulation Therapies." nimh.nih.gov. Tier 2 (U.S. government).

‍

Further reading (external resources): NIMH, Depression; Mayo Clinic, Transcranial Magnetic Stimulation.

‍

# min read

Complex PTSD Recovery Stages: A Comprehensive Guide to Healing

By

Sonia Garcia

|

July 3, 2025

Complex post-traumatic stress disorder (CPTSD) is a unique form of traumatic stress disorder. It develops as a result of prolonged exposure to traumatic events, especially in situations where escape or avoidance is not possible. Unlike classic PTSD, complex PTSD is characterized not only by a reaction to a single traumatic event. Profound changes in emotional regulation, self-perception, and relationships with others also characterize it.

Structured recovery stages play a key role in healing from this problem. They provide a solid foundation for gradual and steady progress. This allows people to move at their own pace, respecting their path to recovery. It is important to realize that healing is possible. Remember, many people successfully overcome the effects of trauma and return to a full and fulfilling life.

What are the symptoms of complex PTSD?

Complex PTSD manifests itself through many interrelated symptoms. Each of them can significantly affect a person's daily life. When the problem is pronounced, not all symptoms necessarily manifest. But some symptoms include:

  • Flashbacks formation and intrusive memories. They can occur suddenly and can be extremely realistic. A person may not only visually relive the traumatic events but may also experience physical sensations, smells, and sounds associated with the trauma. These memories often invade the mind without warning, disrupting daily activities.
  • Avoidance of reminders of the trauma. This problem with CPTSD manifests itself in a desire to avoid places, people, or situations that may trigger painful memories. It can lead to a significant narrowing of living space and social isolation.
  • Difficulty regulating emotions. These conditions manifest themselves in sudden mood swings, outbursts of anger, or deep sadness. The person may have difficulty identifying their feelings or feel emotionally numb.
  • Chronic feelings of guilt, shame, or worthlessness. These symptoms often become part of the self-image. People may constantly criticize themselves, feeling "spoiled" or unworthy of happiness and love.
  • Dissociation and feeling disconnected from reality. These problems can manifest as a feeling of unreality about what is happening, disconnected from one's own body or emotions. Some describe it as a feeling of "autopilot" or watching your life from the outside.
  • Difficulty trusting and maintaining relationships. In complex PTSD, these symptoms are often associated with a deep distrust of people and fear of betrayal. It can manifest in difficulty establishing intimacy, maintaining friendships, or creating romantic connections.

The Three Key Stages of Complex PTSD Recovery

Healing from CPTSD is a structured process that requires a sequential approach. The recovery stages allow for a gradual progression toward recovery, taking into account the individual characteristics of each person. Although the path is not always linear, each stage sets the stage for the next step toward healing.

Establishing Safety and Stabilization

The first and fundamental recovery stages begin with creating a safe physical and emotional environment. This is the cornerstone of the healing process, without which no further progress is possible.

Creating physical safety includes:

  • Providing safe housing
  • Establishing a stable daily routine
  • Meeting basic needs for food, sleep, and physical activity
  • Ensuring financial stability

Developing emotional safety involves:

  • Mastering stress management techniques (deep breathing, meditation)
  • Practicing grounding exercises
  • Working with a professional therapist
  • Creating a support system of trusted people

At Amae Health, specialists help develop an individualized stabilization plan tailored to each person's unique needs and circumstances. Regular sessions with a therapist create a safe space to explore emotions and develop coping skills.

Processing Traumatic Memories

Once a sufficient level of stability has been achieved, the second stage of overcoming PTSD begins - working with traumatic memories. This stage requires special care and professional support.

Methods of trauma-focused therapy:

  • EMDR (Eye Movement Desensitization and Reprocessing):
    • Helps to process traumatic memories
    • Reduces the emotional intensity of the memories
    • Promotes integration of traumatic experiences
  • Cognitive Behavioral Therapy (CBT):
    • Helps identify and change unhealthy thinking patterns
    • Develops anxiety management skills
    • Teaches more adaptive ways of responding
  • Somatic Therapy:
    • Works with the bodily manifestations of trauma
    • Helps to reconnect with the body
    • Develops the ability to feel safe on a physical level

It is important to realize that processing traumatic memories is not simply retelling traumatic events. It is a controlled process designed to integrate the experience without re-traumatizing it. Grieving and mourning losses are a natural part of this process.

Reconnecting with Daily Life

The third recovery stage focuses on reintegration into everyday life and building a new future. This is when a person re-establish social ties and finds new meaning in life.

Key aspects of reintegration:

  • Rebuilding relationships:
    • The gradual building of trust
    • Developing communication skills
    • Establishing healthy boundaries
  • Developing interests and hobbies:
    • Exploring new activities
    • Returning to previous hobbies
    • Developing creative self-expression
  • Setting and achieving goals:
    • Starting with small, achievable goals
    • Gradually expanding horizons
    • Celebrating each success

It's important to remember that progress is rarely linear. Temporary setbacks are a normal part of the recovery process, not a sign of failure.

Therapeutic Approaches in CPTSD Recovery

Psychotherapy Modalities

Amae Health utilizes a variety of therapeutic approaches tailored to each client's individual needs:

  • Dialectical Behavioral Therapy (DBT):
    • Develops emotional regulation skills
    • Teaches acceptance and change
    • Helps you cope with crises
  • Intra-Family Systems Therapy (IFS):
    • Works with different parts of the personality
    • Helps restore inner harmony
    • Promotes self-understanding and acceptance
  • Somatic Therapy:
    • Restores connection with the body
    • Helps to recognize and regulate bodily sensations
    • Develops resource states

Medication Management

Medication therapy can be a useful adjunct to psychotherapy, although it is not in itself a treatment for CPTSD.

The main groups of medications are:

  • Antidepressants (SSRIs, SNRIs) - help manage symptoms of depression and anxiety
  • Mood stabilizers - maintain emotional stability
  • Sleep medications - help with sleep disorders

It is important to remember that any medication should only be taken under the supervision of a qualified professional. While medications may alleviate certain symptoms, lasting improvement in CPTSD often comes through trauma-focused therapy. Intensive trauma-based treatments have been shown to significantly reduce CPTSD symptoms, with over 85% of patients in one study no longer meeting diagnostic criteria after just eight days of structured therapy.

Holistic & Self-Help Strategies for CPTSD Recovery

Lifestyle Adjustments for Long-Term Healing

Physical Well-being:

  • Regular exercise helps reduce stress and improve mood
  • A healthy diet supports energy balance
  • Quality sleep helps restore the nervous system

Emotional Well-being:

  • Practicing mindfulness helps you stay in the present moment
  • Meditation reduces anxiety and improves concentration
  • Breathing exercises help regulate the emotional state

Building a Personal Support Network

Importance of social support:

  • Support groups provide an opportunity to socialize with people with similar experiences from complex PTSD
  • Online forums can be a source of information and support
  • Healthy boundaries protect against re-traumatization

Building supportive relationships:

  • Gradual development of trust
  • Open communication about your needs
  • Respect for personal boundaries

Your Recovery Journey: What Comes Next?

Recovery from CPTSD is a journey that takes time, patience and support. Every step forward, even the smallest, is a meaningful accomplishment. It is important to remember that you are not alone on this journey.

‍The leadership team at Amae Health brings together deep clinical expertise, personal commitment, and a mission to guide you through every step of recovery. Our professionals take a comprehensive approach, combining a variety of therapies and support methods customized to your individual needs.

Recovery is possible. Every day, people overcome the effects of trauma and return to a full life. Your ability to seek help is already a manifestation of your inner strength and commitment to healing.

Remember what is important in the recovery process:

  • Move at your own pace
  • Celebrate every accomplishment, even small ones
  • Be patient and kind to yourself
  • Don't hesitate to ask for help when you need it

Recovery stages from CPTSD may seem difficult, but each step brings you closer to healing. With the right support and tools, you can build a new, more fulfilling life after trauma.

‍

# min read

TMS vs Ketamine and Spravato for Treatment-Resistant Depression

By

Sonia Garcia

|

October 5, 2026

If you are comparing TMS, ketamine, and Spravato for depression, you have probably reached the point where standard antidepressants have not done enough. All three are evidence-based options for treatment-resistant depression, and beyond that they have little in common. TMS is a course of magnetic stimulation delivered while you sit awake in a chair. Ketamine is an anesthetic given by IV, used off-label for depression. Spravato is a nasal spray made from esketamine, one of the two mirror-image forms that make up ketamine, with its own FDA approval and its own rulebook.

‍

None of the three is universally better. They differ in mechanism, speed, setting, and monitoring, and the right one depends on your clinical history and how you respond. Treatment-resistant depression generally means depression that has not adequately improved after at least two antidepressants taken at a proper dose for long enough, and that is the group where all three are most often used.

What Is TMS?

Transcranial magnetic stimulation uses a coil placed against the scalp to deliver focused magnetic pulses to the left dorsolateral prefrontal cortex, a region involved in mood regulation. The FDA first cleared TMS for major depressive disorder in 2008, according to the National Institute of Mental Health. It is delivered in an office, with no anesthesia and no medication.

‍

Our standard TMS course runs 20 to 30 daily sessions over four to six weeks, each 30 to 40 minutes long. You stay awake throughout and drive yourself home afterward. In real-world outcome data from 42 U.S. practices, more than half of patients with medication-resistant depression responded to a standard course, and more than a third reached remission.

What Is Ketamine Therapy?

Ketamine has been an FDA-approved anesthetic since 1970. Its use for depression is off-label: prescribed for a purpose the FDA has not formally approved, which is legal and common in medicine but leaves the safeguards less standardized. It is usually given as an IV infusion in a monitored clinic, as a series of sessions over a few weeks.

‍

Ketamine blocks the NMDA receptor, a glutamate receptor, rather than acting on serotonin like standard antidepressants, and that difference is thought to explain its speed. In a landmark 2006 trial, 18 people with treatment-resistant depression received a single infusion of 0.5 mg/kg, and their symptoms improved significantly within 110 minutes. By the next day, 71% had responded and 29% were in remission. One week later, 35% still met the response threshold. Rapid, real, and often short-lived.

‍

The catch is in the monitoring. Ketamine causes dissociation, a sense of detachment from your body or surroundings, plus sedation and blood pressure rises during and after the infusion, so you are observed until those effects pass and cannot drive that day. In a 2017 consensus statement in JAMA Psychiatry, an American Psychiatric Association task force found the evidence for rapid antidepressant effects convincing but the studies small, the longer-term efficacy data lacking, and the safety data on repeated dosing limited.

What Is Spravato (Esketamine)?

Ketamine is a mixture of two mirror-image molecules. Spravato is esketamine, one of those two, delivered as a nasal spray. Unlike IV ketamine, it has FDA approval for depression. The original approval came in March 2019 for treatment-resistant depression alongside an oral antidepressant, a second indication followed for adults with major depressive disorder and acute suicidal thoughts or behavior, and in January 2025 the FDA approved Spravato as a standalone monotherapy for treatment-resistant depression, with no oral antidepressant required, per the current prescribing information.

‍

That approval comes with a rulebook. Spravato can only be given at a setting certified under a Risk Evaluation and Mitigation Strategy (REMS) program: you take the spray under supervision, you are monitored for at least two hours before an assessment clears you to leave, and you cannot drive until the next day after a restful sleep. Its label carries a boxed warning for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors in younger patients.

‍

So is Spravato the same as ketamine? Related, not identical: same molecular family, same receptor, similar rapid onset and dissociative effects, but a different route, a formal FDA indication, and mandatory monitoring rules that off-label ketamine does not carry. For most people comparing TMS vs Spravato, those rules and insurance coverage are the practical differences that matter.

TMS vs Ketamine vs Spravato: Side-by-Side Comparison

Feature TMS IV ketamine Spravato (esketamine)
Mechanism Magnetic pulses stimulate the prefrontal cortex NMDA receptor antagonist, given intravenously NMDA receptor antagonist, nasal spray
FDA status Cleared for MDD (2008) and OCD (2018) Approved as an anesthetic; off-label for depression Approved for TRD (2019 with an oral antidepressant; 2025 as monotherapy) and for MDD with acute suicidal ideation
Onset Gradual, across a multi-week course Hours to days Hours to days
Session format 30 to 40 minutes, awake, in an office Infusion in a monitored clinic Self-administered spray under supervision in a certified setting
Monitoring None after the session Observed during and after the infusion At least two hours after each dose
Driving Drive yourself home Not that day Not until the next day
Typical course 20 to 30 daily sessions over 4 to 6 weeks A series of infusions over several weeks, then maintenance as needed Twice a week for the first four weeks, then weekly, with later dosing individualized
Common side effects Scalp discomfort, headache Dissociation, sedation, blood pressure rise, nausea Dissociation, dizziness, nausea, sedation, vertigo, raised blood pressure

Onset and Duration of Effect

Speed is the clearest dividing line. TMS builds gradually, and many people do not notice a clear change until the second or third week or later. Ketamine and Spravato can shift symptoms within hours to days.

‍

Speed and staying power are different things. Ketamine's effect after a single infusion often fades within a week or two, which is why it is given as a series with maintenance dosing. Spravato starts at twice a week and tapers, with the need for continued treatment reassessed along the way. Research on durability is still developing for all three, and none should be described as permanent.

Side Effects and Safety Considerations

TMS side effects are local and short-lived: scalp discomfort where the coil sits, headache, and sometimes brief lightheadedness or facial muscle twitching during the pulses. These usually settle within the first week, and because nothing enters the bloodstream there is no weight gain, sexual dysfunction, or sedation. Seizure is the one serious risk, exceedingly rare, and TMS is not used in people with a seizure history, metal in the head, or implanted electronic devices.

‍

Ketamine and Spravato share a different profile. The most common reactions to Spravato in trials were dissociation, dizziness, nausea, sedation, vertigo, numbness, anxiety, lethargy, increased blood pressure, vomiting, feeling drunk, and headache. Those effects peak in the hours after dosing, which is what the monitoring window is for, and both drugs carry a potential for misuse that shapes who is a candidate. Each option has its own screening, and a contraindication to one does not rule out the others.

Cost and Insurance

For TMS, most commercial insurers cover treatment for major depressive disorder once eligibility criteria are met, typically a confirmed diagnosis and documented antidepressant trials without adequate relief. Prior authorization is standard. For TMS we take all commercial insurance plans, cash pay is available, and authorization is something our intake team manages for you.

‍

Spravato is more commonly covered than off-label ketamine because it has an FDA indication insurers can write criteria around, though prior authorization and documentation of failed antidepressant trials are typically required. Ketamine infusion coverage varies widely, and many clinics are self-pay. Published cost estimates vary so much by dose, frequency, and insurance status that a single dollar figure would mislead; ask each provider and your insurer directly.

Can These Treatments Be Combined?

Sometimes, and the research is early. A 2024 systematic review found six published studies on combining TMS with ketamine, mostly case reports plus one retrospective review and one small pilot, and reported substantial and sustained improvement with generally mild side effects. The authors also said the designs were too varied and the samples too small for firm conclusions, and called for randomized trials.

‍

In practice, TMS and Spravato are sometimes used one after the other. Combining any of these is a clinical judgment a psychiatrist makes from your history, not a general recommendation, and the more common pattern is to use one, assess the response, then decide.

Choosing Between Them: What Influences the Decision

A psychiatrist weighing these options usually works through a short list:

‍

  • Treatment history. Which antidepressants, at what doses, for how long, and whether psychotherapy has been tried.
  • How urgently relief is needed. When symptoms are severe or suicidal thoughts are present, a faster-acting option may take priority, alongside care for suicidal thoughts.
  • Tolerance for the experience. Dissociation and a two-hour monitored window, versus a daily half-hour appointment for several weeks with no drug effects.
  • Practical constraints. Whether you can get to daily sessions, whether someone can drive you home after Spravato or ketamine, and what your insurance will authorize.
  • Health factors. Seizure history, metal implants, blood pressure, and any history of substance misuse each rule options in or out.
  • What else is in place. Any of the three works better inside ongoing psychiatric care and therapy than as a standalone fix.

Making the Decision With an Integrated Care Team

TMS, ketamine, and Spravato are tools, and tools do their best work inside a plan: a psychiatrist who knows your history, a therapist working alongside the biological treatment, and a team that notices when the plan needs to change.

‍

That is how we work. At Amae, our one-team care model combines psychiatry, therapy, primary care, and peer support, and TMS and Spravato are available through our Los Angeles and Bay Area clinics as part of that care. If you have been through the antidepressant cycle and want a clear, unhurried look at what comes next, talk with an Amae psychiatrist about your options. If you are in crisis or thinking about suicide, call or text 988 now.

Frequently Asked Questions

What is the difference between TMS and ketamine for depression?

TMS stimulates the brain with magnetic pulses over a course of daily outpatient sessions, with no drug, no sedation, and no monitoring afterward. Ketamine is a medication that acts on NMDA receptors, given by infusion or, as esketamine, by nasal spray, with monitored sedation and dissociation and often faster but shorter-lived effects.

Is Spravato the same as ketamine?

Related but not identical. Spravato is esketamine, the S-enantiomer of the ketamine molecule, delivered as an FDA-approved nasal spray under a required monitoring program. Ketamine infusions use the full ketamine compound and are prescribed off-label for depression, without an FDA indication for that use.

Is Spravato only approved with an antidepressant?

Not anymore. The original 2019 approval was for use alongside an oral antidepressant, and in January 2025 the FDA also approved Spravato as a standalone monotherapy for adults with treatment-resistant depression. Whether it is used alone or with an antidepressant is a decision your psychiatrist makes based on your situation.

Which works faster, TMS or Spravato?

Spravato. Esketamine and ketamine can produce symptom change within hours to days, while TMS builds gradually across a four-to-six-week course. Faster onset does not mean more durable improvement, and both durability and side effects belong in the comparison.

Can TMS and Spravato be used together?

Sometimes, as a clinical decision made with a psychiatrist based on your individual history. Both can be part of a broader treatment-resistant depression plan alongside medication and therapy, and the evidence on combining them is still early.

Is ketamine or Spravato covered by insurance?

Spravato is more commonly covered, because it has an FDA indication insurers can build criteria around, though prior authorization and proof of failed antidepressant trials are usually required. Coverage for off-label ketamine infusions varies widely and is often self-pay. Confirm with the provider and your insurer before starting.

‍

Citations

  1. National Institute of Mental Health. Brain Stimulation Therapies. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies
  2. Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depression and Anxiety. 2012. https://pubmed.ncbi.nlm.nih.gov/22689344/
  3. Zarate CA, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry. 2006. https://pubmed.ncbi.nlm.nih.gov/16894061/
  4. Sanacora G, Frye MA, McDonald W, et al. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry. 2017. https://pubmed.ncbi.nlm.nih.gov/28249076/
  5. U.S. Food and Drug Administration. Drugs@FDA: SPRAVATO (esketamine), NDA 211243, approval history. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211243
  6. U.S. Food and Drug Administration. SPRAVATO (esketamine) nasal spray prescribing information, revised January 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211243s016lbl.pdf
  7. Arubuolawe OO, Folorunsho IL, Busari AK, et al. Combination of transcranial magnetic stimulation and ketamine in treatment-resistant depression: a systematic review. Cureus. 2024. https://pubmed.ncbi.nlm.nih.gov/39156335/
  8. 988 Suicide and Crisis Lifeline. https://988lifeline.org

‍